- 1、本文档共6页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
利奈唑胺补救治疗成人革兰阳性菌感染性心内膜炎的临床分析
Asian Case Reports in Vascular Medicine 亚洲心脑血管病例研究, 2017, 5(1), 1-6
Published Online February 2017 in Hans. /journal/acrvm
/10.12677/acrvm.2017.51001
A Clinical Analysis of Linezolid as
Rescue Treatment for Adult
Gram-Positive Bacterial
Infective Endocarditis
*
Wenjing Wang, Zhen Tao , Yuying Shen, Yanliang Zhang, Huiling Wu
Nanjing Medical University Affiliated Hospital, Nanjing Jiangsu
th th th
Received: Feb. 8 , 2017; accepted: Feb. 25 , 2017; published: Feb. 28 , 2017
Abstract
Objective: Retrospective study was carried out to evaluate the efficacy and safety of Linezolid as
rescue treatment for adult gram-positive bacterial infective endocarditis. Methods: The study
comprised 36 patients from department of infectious disease in Nanjing hospital affiliated to
Nanjing Medical University, between 2008 and 2012. Fifteen patients enrolled in L group received
Linezolid as rescue treatment for infective endocarditis which were unsuccessfully treated. Other
twenty-one patients received conventional antibiotic therapy (Control group). We described base-
line characteristics of the study population and compared L group with control group for the effi-
cacy and the safety of treatment. The data were analyzed by SPSS software. Results: The thir-
ty-three patients in two groups received effective treatment. No significant differences in the cure
rate (80% vs. 81%) and in mortality (6.7% vs. 9.5%) were observed. Thrombocytopenia was
present in only one patient of L group, and others were well tolerated. When we ended the Linezo-
lid for treatment, the patients get well from thrombocytopenia. Conclusions: Linezoli
文档评论(0)